lorazepam has been researched along with warfarin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bertucci, C; Domenici, E; Salvadori, P; Wainer, IW | 1 |
| Fitos, I; Lagercrantz, C; Larsson, T; Simonyi, M; Sjöholm, I; Tegyey, Z | 1 |
| Chosson, E; Farinotti, R; Gimenez, F; Uzan, S; Wainer, IW | 1 |
| Fitos, I; Kardos, J; Visy, J | 1 |
| Duckworth, J; Kaplan, PW | 1 |
| Chung, JY; Hatley, O; Kim, Y; Lee, H; Lee, HA; Rhee, SJ; Yi, S; Yoon, S; Yu, KS | 1 |
1 review(s) available for lorazepam and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for lorazepam and warfarin
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites.
Topics: Allosteric Regulation; Allosteric Site; Benzodiazepines; Chromatography, High Pressure Liquid; Humans; Lorazepam; Oxazepam; Protein Binding; Serum Albumin; Stereoisomerism; Warfarin | 1991 |
Stereoselective binding of 3-acetoxy-, and 3-hydroxy-1,4-benzodiazepine-2-ones to human serum albumin. Selective allosteric interaction with warfarin enantiomers.
Topics: Benzodiazepines; Diazepam; Humans; Lorazepam; Oxazepam; Research Design; Serum Albumin; Stereoisomerism; Structure-Activity Relationship; Ultrafiltration; Warfarin | 1986 |
Influence of specific albumin ligand markers used as modifiers on the separation of benzodiazepine enantiomers by chiral liquid chromatography on a human serum albumin column.
Topics: Anti-Anxiety Agents; Chromatography, Affinity; Chromatography, Liquid; Humans; Ligands; Lorazepam; Oxazepam; Serum Albumin; Stereoisomerism; Temazepam; Warfarin | 1993 |
Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction.
Topics: Allosteric Regulation; Humans; In Vitro Techniques; Kinetics; Lorazepam; Macromolecular Substances; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Stereoisomerism; Warfarin | 2002 |
Confusion and SIRPIDs regress with parenteral lorazepam.
Topics: Aged; Anticoagulants; Anticonvulsants; Confusion; Consciousness Disorders; Diabetes Complications; Electroencephalography; Female; Humans; Lorazepam; Seizures; Status Epilepticus; Warfarin | 2011 |
Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulation.
Topics: Adult; Asian People; Computer Simulation; Cytochrome P-450 Enzyme System; Female; Glucuronosyltransferase; Humans; Liver-Specific Organic Anion Transporter 1; Lorazepam; Male; Metoprolol; Midazolam; Middle Aged; Models, Biological; Omeprazole; Rosuvastatin Calcium; Software; Warfarin; Young Adult | 2019 |